Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics
The aim of the review was to analyze the availability of insulin therapy and the ways to improve it in countries with the largest number of patients with diabetes. It was also aimed to assess the medical, social and economic importance of insulin therapy and industrial production of therapeutic reco...
Saved in:
| Main Author: | S. V. Ponomarenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2019-10-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/299 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic simulation of delayed results of the treatment of type 2 diabetes mellitus with modern insulin analogsin comparison with oral hypoglycemic agents
by: Ivan Ivanovich Dedov, et al.
Published: (2010-03-01) -
Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
by: I Yu Demidova, et al.
Published: (2009-06-01) -
Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study
by: Irina A. Proskurina, et al.
Published: (2016-07-01) -
Chromatographic and massspectrometric analysis of glycosylated recombinant human insulin.
by: M. N. Korchaznikova, et al.
Published: (2009-10-01) -
On the centenary of the insulin discovery
by: I. I. Dedov, et al.
Published: (2021-02-01)